Dichlorphenamide

• Description:

  Dichlorphenamide (Diclofenamide) is an orally active, specific, carbonic anhydrase inhibitor. Dichlorphenamide can reduce intraocular pressure by inhibiting the secretion of water from the eye. Dichlorphenamide can be used for glaucoma research[1].

• Product Name Alternative:

  Diclofenamide

• UNSPSC:

  12352005

• Hazard Statement:

  H302, H361

• Target:

  Carbonic Anhydrase

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/Dichlorphenamide.html

• Purity:

  98.49

• Solubility:

  DMSO : 100 mg/mL (ultrasonic)

• Smiles:

  O=S(C1=CC(Cl)=C(Cl)C(S(=O)(N)=O)=C1)(N)=O

• Molecular Formula:

  C6H6Cl2N2O4S2

• Molecular Weight:

  305.16

• Precautions:

  H302, H361

• References & Citations:

  [1]Kanski, J.J., Carbonic anhydrase inhibitors and osmotic agents in glaucoma. Carbonic anhydrase inhibitors. Br J Ophthalmol, 1968. 52 (8) : p. 642-3.|[2]Rucquoy, M. and L. Sorel, Diclofenamide in the treatment of therapy-resistant epilepsy. Acta Neurol Belg, 1978. 78 (3) : p. 174-82.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category:

  Reference compound1

• Clinical Information:

  Launched

• CAS Number:

  [120-97-8]